OFIXOrthofix Medical Inc.vs its industry peers
A metric-by-metric comparison of Orthofix Medical Inc. against SIC 3841 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OFIX본 종목 | $364M#8 | — | 0.8x#2 | 0.4x#2 | 2.9%#8 | 26.8%#5 | -9.9%#6 | -21.5%#6 | -14.9%#5 | 5#3 | -39.7%#4 | — |
| SGHT | $445M#1 | — | 8.4x#11 | 5.8x#7 | -3.1%#10 | 25.4%#6 | -48.0%#9 | -72.6%#11 | -266.6%#12 | 5#3 | — | — |
| CARL | $421M#2 | 140.3x#6 | 5.0x#10 | 8.3x#12 | 85.9%#2 | -22.2%#11 | -60.5%#12 | -35.2%#9 | -57.3%#10 | 5#3 | — | — |
| CLPT | $407M#3 | — | 37.7x#13 | 11.0x#15 | 17.8%#5 | -35.0%#13 | -65.4%#14 | -237.0%#13 | — | — | 25.2%#2 | — |
| SI | $373M#4 | 0.1x#1 | 3.0x#6 | 7.9x#11 | 49.6%#4 | -158.4%#14 | -55.6%#10 | -32.5%#8 | -22.9%#6 | 3#10 | — | — |
| CTSO | $373M#5 | — | — | 10.1x#13 | 4.1%#7 | 60.4%#4 | -39.8%#8 | — | -122.1%#11 | 4#8 | -67.8%#5 | — |
| OBIO | $368M#6 | — | 3.7x#7 | 11.0x#14 | 1169.2%#1 | 13.6%#8 | -154.7%#15 | -52.8%#10 | -54.9%#9 | — | — | 5.4%#2 |
| MOBI | $366M#7 | — | 2.1x#5 | — | — | — | — | 0.0%#4 | — | — | — | — |
| TLSI | $304M#9 | — | 46.3x#14 | 6.7x#10 | 53.4%#3 | -30.6%#12 | -59.7%#11 | -598.9%#14 | — | 5#3 | 3.8%#3 | — |
| TMCI | $295M#11 | — | 4.4x#9 | 1.4x#3 | 1.6%#9 | -5.8%#9 | -25.5%#7 | -87.1%#12 | -47.4%#8 | 2#11 | — | — |
| EMBC | $296M#10 | 3.6x#2 | — | 0.3x#1 | -3.8%#11 | 21.8%#7 | 22.4%#2 | — | 27.0%#1 | 6#2 | — | 11.8%#1 |
| ANIK | $282M#12 | — | 2.1x#4 | 2.5x#6 | -5.9%#13 | 80.4%#3 | -9.8%#5 | -8.0%#5 | -8.8%#4 | 4#8 | 143.4%#1 | — |
| INFU | $250M#13 | 31.4x#5 | 4.2x#8 | 1.7x#4 | 6.4%#6 | 182.6%#2 | 8.3%#4 | 11.2%#2 | 9.5%#3 | 9#1 | — | — |
| OSUR | $241M#14 | — | 0.8x#1 | 2.1x#5 | -38.1%#15 | -252.5%#15 | -62.6%#13 | -21.6%#7 | -43.8%#7 | — | — | — |
| IDXG | $240M#15 | 9.9x#3 | 10.3x#12 | 6.2x#9 | -17.5%#14 | 267.2%#1 | 10.5%#3 | 105.8%#1 | 14.2%#2 | 5#3 | — | — |
| UTMD | $236M#16 | 22.6x#4 | 1.9x#3 | 6.1x#8 | -5.8%#12 | -18.7%#10 | 29.6%#1 | 9.2%#3 | — | — | — | 1.7%#3 |
Peer set: US filers sharing this company's SEC industry classification (SIC 3841). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice